Elevance Health Inc (NYSE:ELV)
$ 539.18 0.6 (0.11%) Market Cap: 125.32 Bil Enterprise Value: 145.54 Bil PE Ratio: 20.38 PB Ratio: 3.09 GF Score: 92/100

Q4 2023 Elevance Health Inc Earnings Call Transcript

Jan 24, 2024 / 01:30PM GMT
Release Date Price: $473.67 (+0.32%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Elevance Health Fourth Quarter Earnings Conference Call. (Operator Instructions).

I would now like to turn the conference over to the company's management. Please go ahead.

Stephen Vartan Tanal
Elevance Health, Inc. - VP of IR

Good morning, and welcome to Elevance Health's Fourth Quarter 2023 Earnings Call. This is Steve Tanal, Vice President of Investor Relations. And with us this morning on the earnings call are Gail Boudreaux, President and CEO; and Mark Kaye, our CFO; Peter Haytaian, President of Carelon, Morgan Kendrick, President of our Commercial Health Benefits business; and Felicia Norwood, President of our Government Health Benefits business.

Gail will begin the call with a brief discussion of the quarter and year and recent progress against our strategic initiatives. Mark will then discuss our financial results and outlook in greater detail. After our prepared remarks, the team will be available for Q&A. During the call, we will reference certain non-GAAP

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot